{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/454880783"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Bioscience companies face unique challenges, Stern explained: They have greater needs for capital, face higher technical risks and typically need FDA or other regulatory approval before they can market their products or services." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "phys.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/331507217"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/454880783"] } } }
